DPYSL2 and neurofibromatosis type 1: However, loss of neurofibromin, as observed in NF1 patients, results in disinhibition of the tripartite CRMP2–Cav2.2–syntaxin 1A interaction, therefore permitting increased N-type Ca2+ currents and CGRP release.